GE HealthCare (GEHC) reported better-than-expected fourth-quarter profit on Thursday, 🐭while saleꦛs were in line with analysts' estimates.

The medical device maker reported adjusted 澳洲幸运5官方开奖结果体彩网:earnings per share (EPS) of $1.45 on revenue of $5.32 billion. Analysts polled by Visible Alpha expected $1.26 and $5.32 billion, respectively.

GE HealthCare shares, which entered the day up ♓about 3% over the last 12 months, were little changed immediately following the report.

The company said it expects year-over-year organic revenue growth of 2% to 3% in 2025, "which reflects continued demand for our products and services as well as a measured view of market conditions in China." GE HealthCare also projected adjusted EPS between $4.61 and $4.75, up 3% to 6% from the $4.49 it registered in 2024 and mostly above the $4.65 analyst consensus.

澳洲幸运5官方开奖结果体彩网:Last quarter, the former division of conglomerate General Electric topped profit estimates despite what it called "continued market softness" in China, which led GE HealthCare to say it was trending toward the lower end of its 1% to 2% full-year organic revenue growth projection. The firm's 2024ꦏ organic revenue came in a $19.74 billion, up 1%.

GE HealthCare's Q4 results follow those of the other two 澳洲幸运5官方开奖结果体彩网:former GE segments, GE Aerospace (GE) and GE Vernova (GEV). Shares of 澳洲幸运5官方开奖结果体彩网:both rose following 澳洲幸运5官方开奖结果体彩网:their reports late last month.